Stock 1877 SHANGHAI JUNSHI BIOSCIENCES CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Shanghai Junshi Biosciences Co., Ltd.

Equities

1877

CNE100003FF7

Market Closed - Hong Kong S.E.
Other stock markets
 09:08:22 29/04/2024 BST 		5-day change 1st Jan Change
10.84 HKD +0.93% Intraday chart for Shanghai Junshi Biosciences Co., Ltd. +16.68% -44.24%
04-25 Shanghai Junshi Biosciences Receives Hong Kong Approval for Cancer Drug Toripalimab MT
04-24 Shanghai Junshi Biosciences Co., Ltd. Receives Notice from the Drug Office, Department of Health, the Government of the Hong Kong Special Administration Region CI

Evolution of the average Target Price on Shanghai Junshi Biosciences Co., Ltd.

Price target over the last 5 years

History of analyst recommendation changes

13c0a511aeae844.zvPBj9SpFJfLOPySrjA905AVRLsuq66QGvNA1WINo_Y.gaGk5ZzrR9WEb7nw90Zei9R0HIod7OjDQpIUrBd3ka6Lg_PCoe9Y3Y8OxA~3106d5c53ed816c1487261e0361d343d

Analyst Recommendations on Shanghai Junshi Biosciences Co., Ltd.

Shanghai Junshi Biosciences' 2022 Loss Widens, Misses Analysts' Expectations MT
UBS Adjusts Shanghai Junshi Biosciences' Price Target to HK$65.40 From HK$70.90, Keeps at Buy MT
UBS Adjusts Shanghai Junshi Biosciences’ Price Target to HK$70.90 From HK$77.70, Keeps at Buy MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
9.942 CNY
Average target price
22.5 CNY
Spread / Average Target
+126.33%
High Price Target
42.1 CNY
Spread / Highest target
+323.43%
Low Price Target
9.239 CNY
Spread / Lowest Target
-7.07%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Shanghai Junshi Biosciences Co., Ltd.

UBS

Ratings for Shanghai Junshi Biosciences Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. 1877 Stock
  4. Consensus Shanghai Junshi Biosciences Co., Ltd.